Recent Patents on Chemical Engineering
Title:Patent Selections:
Volume: 6 Issue: 3
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Chemical Engineering 2013; 6 (3) . https://dx.doi.org/10.2174/221133470603140411145320
DOI https://dx.doi.org/10.2174/221133470603140411145320 |
Print ISSN 2211-3347 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4788 |
16
Related Articles
-
Molecular Approaches for Neuropathic Pain Treatment
Current Medicinal Chemistry The Efficacy of Cognitive Intervention Programs for Mild Cognitive Impairment: A Systematic Review
Current Alzheimer Research Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Recent Advances in Progressive Supranuclear Palsy: A Review
Current Alzheimer Research Neuropsychiatric Symptoms in Amnestic Mild Cognitive Impairment: Increased Risk and Faster Progression to Dementia
Current Alzheimer Research Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: From Vascular Spasm to Cortical Spreading Depolarizations
Current Neurovascular Research Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms
CNS & Neurological Disorders - Drug Targets Mechanism of Drug and Toxic Actions of Gossypol: Focus on Reactive Oxygen Species and Electron Transfer
Current Medicinal Chemistry Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier
Current Gene Therapy Stability of Methadone and Its Main Metabolite in Oral Fluid
Drug Metabolism Letters Microwave Assisted Prospective Synthesis of New 5-Arylidene Rhodanine Derivatives Bearing a 3-[4-(3-Aminopropyl)piperazin-1-yl]propyl Side Chain
Current Microwave Chemistry Improved Hepatic Differentiation Strategies for Human Induced Pluripotent Stem Cells
Current Molecular Medicine Semicarbazone Analogs as Anticonvulsant Agents: A Review
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammatory Aspects of Depression
Inflammation & Allergy - Drug Targets (Discontinued) Nanoneuromedicines for Neurodegenerative Diseases
Nanoscience & Nanotechnology-Asia Genetic and Environmental Influences on Therapeutic and Toxicity Outcomes: Studies with CYP2A6
Current Clinical Pharmacology Effects of Psychiatric Medications on Sleep and Sleep Disorders
CNS & Neurological Disorders - Drug Targets Recent Insights into the Involvement of Progranulin in Frontotemporal Dementia
Current Neuropharmacology Novel Perspectives in Celiac Disease Therapy
Mini-Reviews in Medicinal Chemistry